STATE OF WISCONSIN INVESTMENT BOARD - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 235 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE OF WISCONSIN INVESTMENT BOARD ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,278,772
+10.7%
83,640
-9.6%
0.01%
+16.7%
Q2 2023$2,059,349
+2.7%
92,555
+0.0%
0.01%0.0%
Q1 2023$2,004,438
-4.2%
92,541
-10.2%
0.01%
-14.3%
Q4 2022$2,092,336
-25.0%
103,020
-5.3%
0.01%
-22.2%
Q3 2022$2,790,000
+2.0%
108,815
-5.4%
0.01%
+28.6%
Q2 2022$2,734,000
-11.4%
114,975
-16.1%
0.01%
+16.7%
Q1 2022$3,085,000
+13.7%
137,0000.0%0.01%
+20.0%
Q4 2021$2,713,000
+0.6%
137,0000.0%0.01%
-16.7%
Q3 2021$2,696,000
-10.6%
137,0000.0%0.01%0.0%
Q2 2021$3,014,000
-7.5%
137,0000.0%0.01%
-14.3%
Q1 2021$3,259,000
-9.1%
137,0000.0%0.01%
-12.5%
Q4 2020$3,584,000
+33.7%
137,000
-11.0%
0.01%
+14.3%
Q3 2020$2,680,000
+3.5%
154,0000.0%0.01%0.0%
Q2 2020$2,590,000
+47.4%
154,000
+4.2%
0.01%
+16.7%
Q1 2020$1,757,000
+0.1%
147,800
+1.9%
0.01%
+50.0%
Q4 2019$1,756,000
-14.4%
145,1000.0%0.00%
-33.3%
Q3 2019$2,051,000
+30.1%
145,100
+2.6%
0.01%
+50.0%
Q2 2019$1,577,000
+2.7%
141,400
+8.1%
0.00%0.0%
Q1 2019$1,536,000
+14.0%
130,800
+29.8%
0.00%0.0%
Q4 2018$1,347,000
-3.4%
100,800
+1.3%
0.00%0.0%
Q3 2018$1,395,000
-10.8%
99,5000.0%0.00%0.0%
Q2 2018$1,564,000
+3.4%
99,500
+8.2%
0.00%0.0%
Q1 2018$1,513,000
+14.8%
92,000
+26.0%
0.00%0.0%
Q4 2017$1,318,000
-6.5%
73,0000.0%0.00%0.0%
Q3 2017$1,409,000
+63.6%
73,0000.0%0.00%
+33.3%
Q2 2017$861,00073,0000.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,825,262$138,6217.54%
Novo Holdings A/S 3,377,768$68,602,4684.28%
Parallel Advisors, LLC 3,724,664$75,647,9263.28%
TANAKA CAPITAL MANAGEMENT INC 35,539$7222.29%
Quantedge Capital Pte Ltd 251,312$5,104,1471.71%
S&T BANK/PA 346,306$7,0331.30%
Freshford Capital Management, LLC 249,000$5,057,1901.09%
Birchview Capital, LP 50,000$1,0160.72%
FAS Wealth Partners, Inc. 306,276$6,220,4660.70%
Bridge City Capital, LLC 60,824$1,2350.63%
View complete list of CORCEPT THERAPEUTICS INC shareholders